Pankaj Kumar Singh

3.2k total citations
127 papers, 2.3k citations indexed

About

Pankaj Kumar Singh is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Pankaj Kumar Singh has authored 127 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 36 papers in Organic Chemistry and 21 papers in Computational Theory and Mathematics. Recurrent topics in Pankaj Kumar Singh's work include Computational Drug Discovery Methods (21 papers), Synthesis and biological activity (17 papers) and Cancer therapeutics and mechanisms (15 papers). Pankaj Kumar Singh is often cited by papers focused on Computational Drug Discovery Methods (21 papers), Synthesis and biological activity (17 papers) and Cancer therapeutics and mechanisms (15 papers). Pankaj Kumar Singh collaborates with scholars based in India, United States and Finland. Pankaj Kumar Singh's co-authors include Om Silakari, Shelly Pathania, Shalki Choudhary, Vijay K. Singh, Oluseyi O. Fatanmi, Himanshu Verma, Stephen Y. Wise, Harpreet Singh, Raj Kumar and Mario Sechi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Pankaj Kumar Singh

114 papers receiving 2.2k citations

Peers

Pankaj Kumar Singh
Nam Doo Kim South Korea
Juan Sun China
Xiao Ding China
Xing Du China
David R. Light United States
Nan Ma China
Nam Doo Kim South Korea
Pankaj Kumar Singh
Citations per year, relative to Pankaj Kumar Singh Pankaj Kumar Singh (= 1×) peers Nam Doo Kim

Countries citing papers authored by Pankaj Kumar Singh

Since Specialization
Citations

This map shows the geographic impact of Pankaj Kumar Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pankaj Kumar Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pankaj Kumar Singh more than expected).

Fields of papers citing papers by Pankaj Kumar Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pankaj Kumar Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pankaj Kumar Singh. The network helps show where Pankaj Kumar Singh may publish in the future.

Co-authorship network of co-authors of Pankaj Kumar Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Pankaj Kumar Singh. A scholar is included among the top collaborators of Pankaj Kumar Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pankaj Kumar Singh. Pankaj Kumar Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aalhate, Mayur, Srushti Mahajan, Pooja Yadav, et al.. (2025). Bovine serum albumin capped lipid nanosystem bearing CDK4/6 inhibitor to combat breast cancer: In-vitro and In-vivo assessment. International Journal of Biological Macromolecules. 333(Pt 2). 148873–148873.
2.
Singh, Pankaj Kumar, et al.. (2025). The intersection of GRK2 and PGE2 in rheumatoid arthritis: a comprehensive update on pathophysiology and treatment. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(10). 13109–13120.
3.
Singh, Pankaj Kumar, et al.. (2024). An ultra broadband metamaterial absorber based on metal-dielectric-metal technology for THz spectrum. Nano Communication Networks. 42. 100531–100531. 4 indexed citations
4.
Kumar, Amandeep, et al.. (2024). Papillary Tumors of Pineal Region: A Single-Center Experience in Management of 11 Cases. World Neurosurgery. 184. e486–e493. 1 indexed citations
5.
Singh, Pankaj Kumar, et al.. (2023). 321P Epidemiology and survival analysis of epithelial ovarian cancer: Results from comprehensive care center in north India. Annals of Oncology. 34. S1596–S1596. 1 indexed citations
6.
Singh, Pankaj Kumar, et al.. (2023). Root Dentin Transparency: A Reliable Method of Age Estimation in Nepalese Population. SHILAP Revista de lepidopterología. 12(2). 3–8.
7.
Verma, Himanshu, Subheet Kumar Jain, Shubham Thakur, et al.. (2023). Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach. International Journal of Biological Macromolecules. 242(Pt 1). 124749–124749. 4 indexed citations
8.
Zarrabi, Ferdows B., et al.. (2023). Developing checkerboard cross element metasurface with multi-Fano response for sensing in the infrared spectrum. Optics Communications. 552. 130060–130060. 2 indexed citations
9.
Derakhshani, Afshin, Zeinab Rostami, Hossein Safarpour, et al.. (2021). From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy. Molecules. 26(8). 2278–2278. 36 indexed citations
10.
Choudhary, Shalki, et al.. (2021). Von Willebrand factor: A key glycoprotein involved in thrombo-inflammatory complications of COVID-19. Chemico-Biological Interactions. 348. 109657–109657. 11 indexed citations
11.
Roy, Tithi, Samuel Boateng, Sergette Banang‐Mbeumi, et al.. (2021). Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation. SHILAP Revista de lepidopterología. 35. 106858–106858. 4 indexed citations
12.
Choudhary, Shalki, et al.. (2020). Pharmacophore-based designing of putative ROS-1 targeting agents for NSCLC. Molecular Diversity. 25(2). 1091–1102. 8 indexed citations
13.
Choudhary, Shalki, Pankaj Kumar Singh, Himanshu Verma, et al.. (2020). Search for non-acidic ALR2 inhibitors: Evaluation of flavones as targeted agents for the management of diabetic complications. Bioorganic Chemistry. 96. 103570–103570. 12 indexed citations
14.
Singh, Pankaj Kumar, et al.. (2018). Counting on Fragment Based Drug Design Approach for Drug Discovery. Current Topics in Medicinal Chemistry. 18(27). 2284–2293. 24 indexed citations
15.
Kaur, Maninder, et al.. (2017). Molecular dynamics and integrated pharmacophore-based identification of dual $$\hbox {JAK3/PI3K}\delta $$ JAK3/PI3K δ inhibitors. Molecular Diversity. 22(1). 95–112. 2 indexed citations
16.
Joshi, Gaurav, et al.. (2015). Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents. Chemico-Biological Interactions. 240. 120–133. 46 indexed citations
17.
Singh, Arun Kumar, et al.. (2012). EFFECT OF FLUMETHRIN ON HEMATOLOGICAL AND BIOCHEMICAL CHANGES IN RATS. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Singh, Vijay K., Oluseyi O. Fatanmi, Pankaj Kumar Singh, et al.. (2012). CBLB613: A TLR 2/6 Agonist, Natural Lipopeptide ofMycoplasma arginini, as a Novel Radiation Countermeasure. Radiation Research. 177(5). 628–642. 61 indexed citations
19.
Singh, Pankaj Kumar, et al.. (2012). Chemical constituents and bio-pharmacological activities of Swertia chirata: A review. 8(6). 4 indexed citations
20.
Singh, Pankaj Kumar, et al.. (2011). Radioprotective efficacy of tocopherol succinate is mediated through granulocyte-colony stimulating factor. Cytokine. 56(2). 411–421. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026